Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of TMC310911 + ritonavir monotherapy in treatment-naïve HIV-1 infection
2008-008190-58Phase 2Completed
- Sponsor
- Tibotec
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of TMC-310911 in Human immunodeficiency virus infection type 1 (4 arms), sponsored by Tibotec. Primary endpoint: Change in plasma HIV-1 viral load from baseline to Day 14. Started Dec 2008; status: completed.
02
Drugs
TMC-310911
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2008-008190-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008190-58.